Single peptide Vial strength 10 mg
Adipotide10 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
Adipotide, explained simply
An experimental peptide designed to target blood vessels supplying adipose tissue, studied in the context of body fat and weight.
Research area
Adipose tissue and body composition
How it works
Its proposed strategy targets vessels supplying white fat, leading to the loss of adipose cells dependent on that network.
Why it matters
It is being explored as an approach distinct from compounds that act mainly on appetite.
What has been observed
Preclinical models have reported changes in fat mass. Human evidence is substantially narrower.
Effects and points to consider
Kidney-related findings warrant attention in Adipotide research; animal results should not be read as established clinical outcomes.
01 / Vial strength 10 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 10 mg Adipotide |
|---|---|
| Final volume | 3 mL |
| Concentration | 3.33 mg/mL |
| One U-100 unit | 33.33 mcg in 0.01 mL |
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 250 mcg | 7.5 units (0.08 mL) |
| Weeks 3–4 | 500 mcg | 15 units (0.15 mL) |
| Weeks 5–6 | 750 mcg | 22.5 units (0.23 mL) |
| Weeks 7–8 | 1000 mcg (1.0 mg) | 30 units (0.30 mL) |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.